At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 360 enrolled
Drug / intervention
FPNS +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Placebo-controlled, Active Comparator, One-Week, Cross-Over, Multicenter Study to Evaluate the Efficacy and Patient Preference of Nasal Spray Characteristics of Once-Daily, Intranasal Administration of 110mcg Fluticasone Furoate Nasal Spray and 200mcg Fluticasone Propionate Nasal Spray in Adult Subjects With Seasonal Allergic Rhinitis
In Brief
A Phase 4 clinical trial evaluating FPNS, FFNS, and 2 other interventions for Rhinitis, Allergic, Perennial. Completed, enrolled 360 participants across 28 sites.
Detailed Summary
The purpose of this replicate study to FFU105924 is to provide data on subject preference of FFNS as compared with FPNS.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhinitis, Allergic, Perennial
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
First PostedAug 2007
Primary CompletionNov 2007
TodayJul 2026
First PostedAug 22, 2007
Enrollment StartAug 1, 2007
Primary CompletionNov 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 18.9 years ago
Interventions
FPNSdrug
fluticasone propionate nasal spray
FFNSdrug
fluticasone furoate nasal spray
placebo FFNSdrug
placebo nasal spray matching fluticasone furoate nasal spray
placebo FPNSdrug
placebo nasal spray matching fluticasone propionate nasal spray